Although deaths from amoebic meningoencephalitis are rare, they could become more common because of climate change.

River blindness and the black flies that cause it torment millions in west Africa. The “slash and clear” method is an effective way to eliminate them at source.

The allocation follows a Gavi Board decision in December 2023 to approve US$ 290 million funding for the “Big Catch-Up” initiative.

Professor Dimie Ogoina was among the first to raise the alarm as mpox spread through Nigeria’s cities in 2017. VaccinesWork spoke to him and the DRC researchers tackling the latest outbreak.

Côte d’Ivoire commits to fully finance its routine immunisation programme over the next five years to ensure sustainability beyond Gavi support.

As extreme heat awareness rises, a One Health approach and robust adaptation strategies are essential for climate-resilient health systems.

Yesterday, Côte d'Ivoire made history by becoming the first country to introduce the R21 malaria vaccine into its routine immunisation programme. We spoke to the country's EPI Director to find out how they plan to roll out this lifesaver.

As South Sudan prepares to deploy a new weapon in its fight against malaria, the R21 vaccine, Winnie Cirino surveys the parasitic disease’s foothold. 

In a historic move to combat the devastating impact of malaria, the Ministry of Health, in partnership with UNICEF and the World Health Organization and Gavi, The Vaccine Alliance, today launched the nationwide rollout of the R21 malaria vaccine…

Gavi, the Vaccine Alliance, has been ranked in the ‘Very good’ category for the fifth time in the 2024 Publish What You Fund (PWYF) Index, a leading assessment of aid transparency.

Lassa fever is brutal, deadly, has pandemic potential, and is only getting more dangerous as the world’s climate changes. A vaccine can’t come soon enough. Is the candidate currently in Phase 2 trials in West Africa on track for success?

Regularly watching sporting events – whether in person or on TV – is linked to higher wellbeing.